BioSpace News Archive

Business

Envista Schedules Second Quarter 2020 Earnings Call

Envista Holdings Corporation (NYSE: NVST) (“Envista”) will report financial results for its second quarter 2020 on Thursday, July 30, 2020.

July 21, 2020
·
2 min read
Pharm Country

FDA Advisory Committee Sets Review Date for Mesoblast’s remestemcel-L in Pediatric Steroid-Refractory Acute Graft Versus Host Disease

Mesoblast Limited (Nasdaq:MESO; ASX:MSB) today announced that the Oncologic Drugs Advisory Committee (ODAC) of the United States Food and Drug Administration (FDA) has scheduled a meeting on August 13, 2020 to review data supporting the Company’s Biologics License Application (BLA) for approval of RYONCIL™

July 21, 2020
·
5 min read
Aurinia Announces U.S. Food and Drug Administration Acceptance of the Filing of New Drug Application and Priority Review for Voclosporin for the Treatment of Lupus Nephritis

Aurinia Pharmaceuticals Inc. (Nasdaq:AUPH / TSX:AUP) (“Aurinia” or the “Company”), a late-stage clinical biopharmaceutical company focused on advancing voclosporin across multiple indications, today announced that the U.S. Food and Drug Administration (FDA) has accepted the filing of its New Drug Application (NDA) for voclosporin,

July 21, 2020
·
9 min read
Business

IQVIA Appoints Ron Bruehlman Executive Vice President and interim Chief Financial Officer

IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of advanced analytics, technology solutions, and contract services to the life sciences industry, today announced the appointment of Ron Bruehlman as Executive Vice President and interim Chief Financial Officer

July 21, 2020
·
4 min read
Bio NC

Kewaunee Scientific Corporation Accelerates Growth in The Middle East & Africa Market by establishing a Local Entity in Saudi Arabia

Kewaunee Scientific Corporation announced it has received the necessary approvals to establish a Technical Service Organization within the Kingdom of Saudi Arabia.

July 21, 2020
·
2 min read